4 years after its launch as manager of cos in J&amp;J’s Belgian incubator, Bioqube has raised €60M toward its 1st independent fund earmarked for European start-ups with $JNJ &amp; $GMAB as strategic LPs. via @BioCentury's @BioBonanos https://t.co/mZxMKdWno4